TELIX Pharmaceuticals Ltd (TLX) — Financial Flexibility Index
TELIX Pharmaceuticals Ltd (TLX) has a Financial Flexibility Index of 0.05x as of June 2025. Free cash flow of AU$38.11 Million (operating CF AU$27.98 Million minus capex AU$10.13 Million) represents 0% of total liabilities (AU$768.01 Million). Check TLX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
TELIX Pharmaceuticals Ltd Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for TELIX Pharmaceuticals Ltd across 8 annual periods. See working capital to net assets of TELIX Pharmaceuticals Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for TELIX Pharmaceuticals Ltd (2017–2024)
Year-by-year free cash flow to debt coverage for TELIX Pharmaceuticals Ltd. For the full company profile including market capitalisation, see TELIX Pharmaceuticals Ltd (TLX) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (AUD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.08x | AU$77.06 Million | AU$43.03 Million | AU$948.22 Million | ▼ -41.6% |
| 2023 | 0.14x | AU$34.68 Million | AU$23.88 Million | AU$249.39 Million | ▲ +149.5% |
| 2022 | -0.28x | AU$-50.11 Million | AU$-63.97 Million | AU$178.44 Million | ▲ +48.6% |
| 2021 | -0.55x | AU$-57.99 Million | AU$-59.33 Million | AU$106.17 Million | ▼ -1986.2% |
| 2020 | 0.03x | AU$2.28 Million | AU$1.96 Million | AU$78.81 Million | ▲ +104.0% |
| 2019 | -0.72x | AU$-22.86 Million | AU$-23.33 Million | AU$31.88 Million | ▲ +16.1% |
| 2018 | -0.85x | AU$-20.34 Million | AU$-20.75 Million | AU$23.80 Million | ▲ +74.5% |
| 2017 | -3.35x | AU$-6.03 Million | AU$-6.03 Million | AU$1.80 Million | — |